We're sorry but this app doesn't work properly without JavaScript enabled. Please enable it to continue. Epic Investment Partners Views: The Week Ahead - MeDirect

Picture your Future. Save for it by earning 1.5% on a 1-year Term Deposit Account! Learn more.

Epic Investment Partners Views: The Week Ahead

The main events this week include the BoJ rate decision (Tue), FOMC meeting (Tue-Wed), UK rate decision (Thu). Given the Israel-Iran conflict markets will closely monitor the impact on the energy market and potential for further escalation.  

Later today we have the US empire manufacturing print, and we will hear from the ECB’s Nagel. Tuesday kicks-off with the BoJ rate decision, a hold at 0.5% is expected. We also have the Germany ZEW survey, and US retail sales, business inventories, import/export prices and industrial production figures. On Wednesday eurozone and UK CPI prints, US housing starts and initial jobless claims, and a raft of ECB speakers will garner market attention. As will the FOMC rate decision, where a hold at 4.25-4.50% is priced in. On Thursday we have the BoE rate decision, a likely hold, and US markets will be closed for the Juneteenth holiday. Eurozone consumer confidence, Japan CPI, UK retail sales, and the US Conf. Board leading Index and Phili. Fed services are due on Friday.  

Renewed optimism over progress on the US-China trade talks supported improved risk sentiment earlier in the week. We also had Trump’s announcement of unilateral tariffs, World Bank growth forecasts and easing US inflation prints. Having started the week on a positive note the S&P Index closed ~0.40% lower. Meanwhile, the US Treasury curve benefited from concerns over tariffs and subsequent outlook on the US economy, the yield on the 10-year rallied 11bps to 4.40%. The dollar had a torrid week, with the DXY Index falling 1.01%. Brent crude gained 11.67%, closing at $74.23pb amid heightened geopolitical tensions.  

US CPI data for May came in softer than expected, with both headline and core inflation rising just 0.1%mom versus forecasts of 0.2%mom and 0.3%mom, respectively. This marks the fourth consecutive month of downward CPI surprises, though businesses continue to warn of higher costs as tariff uncertainties remain unresolved. PPI readings also surprised to the downside, rising 2.6%yoy and 3.0%yoy, respectively. The Uni. of Michigan sentiment prints rose above expectations, while the inflation expectations eased: 1-year to 5.1% (exp.6.4%) and the 5-10 year at 4.1% (from 4.2%) 

The World Bank slashed its 2025 global growth forecast to 2.3%, down 0.4%, due to rising trade tensions and uncertainty. The downgrade affected major economies, with the US forecast cut to 1.4%, and additional tariffs potentially reducing global growth by another 0.5%. The organisation expects global inflation at 2.9% in 2025, above pre-pandemic levels, while trade growth is expected to slow significantly to 1.8% this year, from 3.4% in 2024. 

This morning’s China’s retail sales figures for May surprised to the upside (+6.40%yoy), growing at their fastest rates since late-2023 as government subsidies appeared to underpin consumption. Industrial profits marginally missed expectations, expanding at 5.8%yoy, while fixed-asset investment printed a 3.7%yoy gain, below market expectations, as property investment has fallen 10.7% in the first five months this year. Last week China’s State Council upped its real estate support calling for “stronger efforts to stabilise and recover the real estate market,” proposing to integrate high-quality housing development into urban renewal strategies with comprehensive policy measures. This shift aims to transform the sector by moving developer competition away from price wars toward quality-focused development, supported by coordinated urban planning, land supply, fiscal, and financial tools. 

 


Epic Investment Partner’s Key risks & Disclaimers:

EPIC Global Equity Fund (the “Fund”) is a sub-fund of EPIC Funds p.l.c. (the “Company”), which is an open-ended umbrella fund authorised in Ireland as a UCITS fund and regulated by the Central Bank of Ireland. This marketing material has been approved in the UK by EPIC Markets (UK) LLP, trading as EPIC Investment Partners, which is a limited liability partnership incorporated and registered in England and Wales under partnership OC306260 with its registered office at Audrey House, 16-20 Ely Place, London EC1N 6SN. EPIC Markets (UK) LLP is regulated by the Financial Conduct Authority. Distribution of this material and the offer of the Fund are specifically restricted in certain jurisdictions. In particular, but without limitation, neither this material nor shares in the Fund are available to US persons.

This document is for general information purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. It is not a personal recommendation and it should not be regarded as a solicitation or an offer to buy or sell any shares in the Fund. This document represents the views of EPIC Investment Partners at the time of writing. It should not be construed as investment advice. Any person interested in investing in the Fund should conduct their own investigation and analysis of the Fund and should consult their own professional tax, accounting or other advisers as to the risks involved in making such an investment. Full details of the Fund’s investment objectives, investment policy and risks are set out in the Fund’s Prospectus and Supplement which, together with the Key Information Document (“KID”), are available on request and free of charge from Maples Fund Services (Ireland) Limited, 32 Molesworth Street, Dublin 2, Ireland and, in the UK, from EPIC Markets (UK) LLP, Audrey House, 16-20 Ely Place, London EC1N 6SN. Any offering of the Fund is only made on the terms of the current Prospectus, Supplement and KID. A subscription in the Fund can only be made after the provision of the KIID and should be made solely upon the information contained in the Prospectus, Supplement and KID.

An investment in the Fund is not suitable for an investor who cannot sustain a loss on their investment. There is no guarantee of the Fund’s future performance and past performance is not a reliable indicator of future performance. The value of your investment and the income derived from it can go down as well as up, and you may not get back the money you invested. The risks associated with making an investment in the Fund are described in the Prospectus and Supplement but investors should note, in particular, the following: 1) Foreign currency denominated investments are subject to fluctuations in exchange rates that could have a positive or an adverse effect on an investor’s returns. There is also a risk that currency hedging transactions for one share class may in extreme cases adversely affect the net asset value of the other share classes within the same sub-fund since there is no legal segregation between share classes; 2) The Fund is subject to the risk of the insolvency of its counterparties; and 3) Emerging market securities are subject to greater social, political, regulatory, and currency risks than developed market securities. This may impact the liquidity and value of such securities and, consequently, the value of the Fund.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from EPIC Investment Partners. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

Join MeDirect today to access the tools you need to put your money to work on your own terms.

Latest news articles

Epic Investment Partners Weekly Article
All News

Epic Investment Partners Views: The Week Ahead

Markets will focus on key central bank decisions this week (BoJ, Fed, BoE), ongoing US-China trade dynamics, and geopolitical tensions, while data from the US, UK, eurozone, and China influence sentiment amid easing inflation, downgraded global growth forecasts, and mixed economic signals.

Experience better Banking

The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. 


Sign up and open your account for free, within minutes.

MeDirect_Multi-Devices-cards

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.